FDA approves new device to improve symptoms in patients with advanced heart failure
The Barostim Neo System was given a Breakthrough Device designation by the FDA
The Barostim Neo System was given a Breakthrough Device designation by the FDA
SP Scientific and Lab-i-DOSiTECNO sign global partnership agreement
The U.S. Food and Drug Administration has approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis
Approval marks the second drug approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs and signals FDA’s continued focus on facilitating development of new treatments to fight antimicrobial resistant infections
The acquisition of Toronto Research Chemicals brings wide breadth of synthetic and analytical chemistry capabilities
Agreement will address limitations in development of multiplex point-of-care Lateral Flow Assay diagnostic tests
The 30th International Symposium on Human Identification will take place on September 23-26 in Palm Springs, California
Prizes to be awarded to top global and regional submissions
Research led by the University of Edinburgh has developed new data analysis tool in a bid to improve disease progression research
Complementary product portfolios will support and accelerate expansion into the pharmaceutical industry
Thermo Scientific MD portfolio provides an extensive range of chromatography and mass spectrometry instruments for laboratory developed tests
Download the microbiome workflow poster from Eppendorf
RAFA 2019 will take place in Prague, Czech Republic, on 5-8 November, 2019
AKO MED to exclusively distribute Unyvero A50 portfolio in Serbia, North Macedonia, Bosnia Hercegovina, and Montenegro
Next-generation sequencing oligo products to be used in groundbreaking food safety platform
Visitors to earn continuing professional development (CPD) points in the free-to-attend conference programme
Combination of Tecentriq and chemotherapy has demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit